Estithmar Holding Reports Record Half-Year Results for 2025
The company reported revenue of QAR 3.073 billion, an 87% year-on-year increase. Gross profit soared by 134% to QAR 1.054 billion, while EBITDA rose 97% to QAR 732 million compared to H1 2024. Net profit reached QAR 465 million, up 97% year-on-year, while earnings per share (EPS) doubled, reaching QAR 0.130.
While Estithmar Holding continues its upward trajectory in its financial and operational indicators across all its financial disclosures, this remarkable leap in results for H1 2025 is mainly attributed to increased revenue through its international expansions across its 4 sectors in Saudi Arabia, Iraq, Algeria, Libya, Maldives, Jordan, and Kazakhstan.
The company's enhanced operational performance also underpinned an EBITDA of QR 732 million, an increase of 97%, driven by disciplined financial and operational policies, which improved the profit margin.
"Our exceptional first‑half performance demonstrates the strength of our strategy. By focusing on value creation, sector leadership and disciplined capital allocation, we have delivered greater operational efficiency, robust revenue growth and margin expansion' Juan Leon, Group CEO of Estithmar Holding commented, and added, "Sustained and balanced growth across our four clusters remains central to our investment strategy. We continue to drive innovation and adopt advanced operational technologies. With a distinctive blend of capabilities and expertise, Estithmar Holding is well‑placed to deliver exceptional stakeholder value and extend our footprint globally."
Read more on www.estithmarholding.com
Source: AETOSWire
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
UnitedHealth Group Announces Changes to Leadership Team
July 31, 2025--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced Wayne S. DeVeydt has been appointed its chief financial officer, effective September 2, 2025. John F. Rex, who joined the company in 2012 and has been CFO since 2016, will become strategic advisor to the CEO on the same date. "Wayne DeVeydt combines deep financial acumen and operating experience with the mission-oriented and compassionate approach to health care that is a perfect fit for UnitedHealth Group," said Stephen J. Hemsley, company chairman and chief executive officer. "John Rex has been an exceptional leader, having helped guide our company through substantial change with both strategic vision and strong commitment to our mission," said Hemsley. "I look forward to his continued insights as UnitedHealth Group moves forward." DeVeydt, 55, most recently has been a managing director and operating partner at Bain Capital, working with client leaders on operational improvement and growth acceleration. From 2018-2020, he was chairman and CEO of Surgery Partners, Inc. in Nashville, expanding the operational scale and financial performance of the surgical services firm. He joined Anthem, Inc. (now Elevance) in 2005 and served as its chief financial officer from 2007 to 2016. Prior to joining Anthem, DeVeydt served as a partner with PricewaterhouseCoopers LLP, with a focus on the health care sector. "There is no organization besides UnitedHealth Group that presents the kinds of opportunities to make a difference in health care, from individual patient care to broad system efficiency, so I am eagerly looking forward to joining the team," said DeVeydt. "I've been fortunate to know John Rex for over two decades and am honored to follow a leader of his caliber." Rex, 63, joined UnitedHealth Group as chief financial officer of the company's then newly established Optum business and previously had spent his career focused in health care across multiple roles and sectors. "This pivotal moment for UnitedHealth Group is the right time for a new yet greatly experienced executive like Wayne DeVeydt, and I look forward to supporting him and the entire leadership team while continuing to advise on a range of matters," said Rex. About UnitedHealth Group UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at and follow UnitedHealth Group on LinkedIn. View source version on Contacts Media: uhgmedia@ UnitedHealth Group Media Sign in to access your portfolio
Yahoo
13 hours ago
- Yahoo
XRP Edges Out Ethereum in Coinbase Transaction Revenue as Token Shifts Persist
Coinbase's retail trading volumes dropped sharply in Q2, but beneath the surface, XRP continued to generate more consumer transaction revenue than Ethereum, extending a trend that began in the first quarter. According to Coinbase's Q2 shareholder letter, XRP made up 13% of consumer transaction revenue, narrowly ahead of Ethereum at 12%. That marked a shift from Q1, when the asset's share was lower at 10%, while XRP briefly surged to 18%. Overall transaction revenue declined 39% quarter-over-quarter to $764 million, with total net revenue falling short of analyst expectations at $1.5 billion versus a $1.59 billion consensus. 'In Q1, the SEC withdrew its appeal in the Ripple case, affirming that XRP's secondary-market sales weren't securities,' Juan Leon, research analyst at Bitwise Asset Management, told Decrypt. 'That legal win sparked a rally in XRP's price and retail interest in trading the token.' What the GENIUS Act Means for XRP Investors XRP's trading share on Coinbase climbed steadily from under 10% throughout 2024. The token's Q1 jump coincided with a wave of value-seeking traders responding to the legal clarity. But the rally proved short-lived. 'Price momentum subsided in Q2,' Leon noted, with Ethereum regaining ground on the back of institutional flows and renewed ecosystem interest. With fewer new regulatory or product catalysts, 'retail traders shifted back toward Ethereum, where stablecoin activity and DeFi usage were accelerating,' Leon told Decrypt. Leon cites the impact of the GENIUS Act's passage into law and tokenization narratives as key factors to the Ethereum-favored rally, which he said 'notched a 38% return in Q2 vs XRP's 11%.' 'Bizarre Situation': SEC Halts Conversion for Another ETF Holding Bitcoin, Ethereum, and XRP Still, Ethereum's regained footing in Q2 wasn't driven by retail alone. 'Demand for Ethereum is on a surge as a result of inflows via ETFs and purchases from Ethereum treasury companies,' Leon said, explaining how this factor is driving a rally in Ethereum's price. 'We believe strong institutional demand for ETH will carry into the second half of the year.' Other observers pointed to price action and shifting narratives as key drivers behind the reversal. 'XRP's Q1 retail rise was driven by legal clarity and low-cost appeal, attracting value-focused traders,' Hank Huang, CEO of Kronos Research, told Decrypt. Ethereum's lag switched up by Q2 amid ecosystem developments and ETF anticipation, which Huang said 'restored investor confidence and liquidity.' Flows from Ethereum ETFs are 'fueling broader ecosystem vitality,' he noted. But the retail boost from Coinbase 'remains price-driven,' and shows how retail sentiment could shift based on 'narratives, market momentum, and macro cues rather than sustained platform engagement,' Huang explained. Min Jung, senior analyst at Presto, echoed that view, adding that Ethereum's underperformance in Q1 as ETH/BTC ratios hit multi-year lows and retail interest waned. The pattern, Jung said, reflects how the 'retail-heavy nature' of Coinbase volumes often reacts to those factors. Ethereum was 'one of the most unloved assets in crypto' at the time, Jung told Decrypt. Despite that, Ethereum began to 'regain momentum' as digital asset treasuries gained traction, Jung said. That factor gave Ethereum 'a fresh narrative,' helping it recover from lagging price and retail interest, he added. Sign in to access your portfolio
Business Wire
a day ago
- Business Wire
LINEAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Lineage, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead the Lineage Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)-- Robbins Geller Rudman & Dowd LLP announces that purchasers of Lineage, Inc. (NASDAQ: LINE) common stock in or traceable to the registration statement used in connection with Lineage's July 2024 initial public offering (the 'IPO'), have until September 30, 2025 to seek appointment as lead plaintiff of the Lineage class action lawsuit. Captioned City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., No. 25-cv-12383 (E.D. Mich.), the Lineage class action lawsuit charges Lineage and certain of its top executives, directors, IPO underwriters, and IPO sponsor with violations of the Securities Act of 1933. If you suffered substantial losses and wish to serve as lead plaintiff of the Lineage class action lawsuit, please provide your information here: CASE ALLEGATIONS: Lineage is a Maryland REIT focused on temperature-controlled cold-storage facilities. In the July 2024 IPO, Lineage sold over 65 million shares of Lineage common stock to investors at $78 per share, raising more than $5 billion in gross offering proceeds. The Lineage class action lawsuit alleges that the registration statement was false and/or misleading and/or failed to disclose that: (i) Lineage was then experiencing sustained weakening in customer demand, as additional cold-storage supply had come on line, Lineage's customers destocked a glut of excessive inventory built up during the COVID-19 pandemic, and Lineage's customers shifted to maintaining leaner cold-storage inventories on a go-forward basis in response to changed consumer trends; (ii) Lineage had implemented price increases in the lead-up to the IPO that could not be sustained in light of the weakening demand environment facing Lineage; (iii) Lineage was unable to effectively counteract the adverse trends listed above through the use of minimum storage guarantees or as a result of operational efficiencies, technological improvements, or its purported competitive advantages; (iv) as a result, rather than enjoying stable revenue growth, high occupancy rates, and steady rent escalation as represented in the registration statement, Lineage was in fact suffering from stagnant or falling revenue, occupancy rates, and rent prices; and (v) consequently, Lineage's financial results, business operations, and prospects were materially impaired. Since the IPO, the price of Lineage stock has fallen to lows near $40 per share. The price of Lineage stock has remained substantially below the IPO price at the time of the filing of the complaint. The plaintiff is represented by Robbins Geller, which has extensive experience in prosecuting investor class actions including actions involving financial fraud. You can view a copy of the complaint by clicking here. THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Lineage common stock in or traceable to the registration statement issued in connection with Lineage's IPO to seek appointment as lead plaintiff in the Lineage class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Lineage class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Lineage class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Lineage class action lawsuit. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices.
